NMRA

Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Watertown, Massachusetts, committed to innovating therapies for neuropsychiatric and neurodegenerative disorders. By harnessing advanced scientific techniques, Neumora aims to tackle significant unmet medical needs through its diverse pipeline of novel compounds, which target vital biological pathways implicated in complex brain diseases. The company’s strategic focus on transformative treatment options positions it to potentially redefine standards of care in neurology and significantly improve patient outcomes.